Aerovate Therapeutics, Inc. (AVTE)
Total Valuation
AVTE has a market cap or net worth of $321.24 million. The enterprise value is $160.70 million.
| Market Cap | 321.24M |
| Enterprise Value | 160.70M |
Important Dates
The next earnings date is Wednesday, June 29, 2022, before market open.
| Estimated Earnings Date | Jun 29, 2022 |
| Ex-Dividend Date | n/a |
Share Statistics
AVTE has 24.41 million shares outstanding. The number of shares has increased by 9,942.29% in one year.
| Shares Outstanding | 24.41M |
| Shares Change (YoY) | +9,942.29% |
| Shares Change (QoQ) | +98.56% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 105.06% |
| Float | 4.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.98 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 35.27, with a Debt / Equity ratio of 0.00.
| Current Ratio | 35.27 |
| Quick Ratio | 34.25 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -25.20%, which is considered low. The company has a ROIC of -49.30%.
| Return on Equity (ROE) | -25.20% |
| Return on Assets (ROA) | -21.10% |
| Return on Capital (ROIC) | -49.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.73M |
| Employee Count | 18 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AVTE has paid $3,000 in taxes.
| Income Tax | 3,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (1Y) | n/a |
| Total Price Change | -6.00% |
| 50-Day Moving Average | 14.21 |
| 200-Day Moving Average | 12.55 |
| Average Volume (30 Days) | 62,284 |
Short Selling Information
The latest short interest is 504,957, so 2.07% of the outstanding shares have been sold short.
| Short Interest | 504,957 |
| Short % of Shares Out | 2.07% |
| Short % of Float | 11.25% |
| Short Ratio (days to cover) | 8.09 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -31.26M |
| Pretax Income | -31.09M |
| Net Income | -31.09M |
| EBITDA | -31.13M |
| EBIT | -31.15M |
| Earnings Per Share (EPS) | -$1.87 |
Balance Sheet
The company has $161.07 million in cash and $528,000 in debt, giving a net cash position of $160.54 million or $6.58 per share.
| Cash & Cash Equivalents | 161.07M |
| Total Debt | 528,000 |
| Net Cash | 160.54M |
| Net Cash Per Share | $6.58 |
| Book Value | 161.95M |
| Book Value Per Share | 6.63 |
| Working Capital | 161.18M |
Cash Flow
In the last 12 months, operating cash flow was -$29.29 million and capital expenditures -$169,000, giving a free cash flow of -$29.45 million.
| Operating Cash Flow | -29.29M |
| Capital Expenditures | -169,000 |
| Free Cash Flow | -29.45M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AVTE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -9.68% |
| FCF Yield | -9.17% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9,942.29% |
| Shareholder Yield | -9,942.29% |
Analyst Forecast
The average price target for AVTE is $24.99, which is 89.89% higher than the current price. The consensus rating is "Buy".
| Price Target | $24.99 |
| Price Target Difference | 89.89% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |